1571 related articles for article (PubMed ID: 9321512)
21. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
Park YH; Jung BH; Chung BC; Park J; Mitoma C
Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
[TBL] [Abstract][Full Text] [Related]
22. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.
Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J
Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963
[TBL] [Abstract][Full Text] [Related]
23. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
26. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
27. Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation.
Lin JH; Chen IW; Chiba M; Nishime JA; Deluna FA
Drug Metab Dispos; 2000 Apr; 28(4):460-6. PubMed ID: 10725315
[TBL] [Abstract][Full Text] [Related]
28. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
29. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
32. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
33. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
Colletti AE; Krieter PA
Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
[TBL] [Abstract][Full Text] [Related]
34. Disposition of [14C]avitriptan in rats and humans.
Marathe PH; Greene DS; Barbhaiya RH
Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
37. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
Jezequel SG; Uden S; Wastall P
Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
39. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
